PALAXPRESS ULTRA POWDER AND LIQUID PINK 66034252

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,05,07 report with the FDA on 2012-11-19 for PALAXPRESS ULTRA POWDER AND LIQUID PINK 66034252 manufactured by Heraeus Kulzer Gmbh.

Event Text Entries

[2997390] On (b)(6) 2012 we were informed that palaxpress ultra was used to produce the denture for a pt. Fourteen days after wearing it the pt experienced redness and blisters of the mucosa. The denture was stored in water and the status of the dentist is monitoring the pt's health. On (b)(6) 2012 we were informed that the pt was referred to the hospital. The dental lab stated there is no connection between the denture and the referral to the hospital. On (b)(6) 2012 hk product safety manager spoke to the dentist and was informed that the pt is back at home. The dentist was not clear if the denture and the referral to the hospital are connected. The pt is now wearing her old denture. The dentist will get in touch with hkg if the pt status would change/get worse. On (b)(6) 2012 safety manager spoke to the dentist. The dentist said that the complete maxillary denture made out of palaxpress ultra was delivered to the pt in the middle of (b)(6) 2012. About one week later the pt experienced swelling of the face and increased number of leukocytes. The pt spent a few days in the hospital for treatment. The denture was worn until (b)(6) and then exchanged for the old one. The health situation of the pt has been improved since then, but the symptoms have not completely resolved. The pt receives out-patient treatment by several doctors, but not at the dentist's office. The dentist could not provide any info on the medical treatment of the pt, because he is not involved in the process. The palaxpress ultra denture will be reintroduced to the pt when the pt has recovered completely from the symptoms. We will continue to monitor the pt's recovery.
Patient Sequence No: 1, Text Type: D, B5


[10262567] As allowed by (b)(4), (the importer) is submitting the report on behalf of heraeus kulzer (b)(4) (the manufacturer). Although we have not established that the device caused or contributed to the event, we're reporting it out of caution to be compliant with 21 cfr part 803. Conclusion - the directions for use gives the following warning, "product contains polymerized monomers (e. G. Methacrylates/acrylates), which may irritate the skin. If any irritation appears or known allergies exist with resins based on methacrylates or acrylates, the product should not be used. "
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number9681707-2012-00010
MDR Report Key2851331
Report Source01,05,07
Date Received2012-11-19
Date of Report2012-10-24
Date of Event2012-09-22
Date Facility Aware2012-10-29
Report Date2012-10-24
Date Mfgr Received2012-10-24
Date Added to Maude2012-11-30
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationDENTIST
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location3
Manufacturer ContactAUDI BOGUCKI, RDH
Manufacturer Street300 HERAEUS WAY
Manufacturer CitySOUTH BEND IN 46614
Manufacturer CountryUS
Manufacturer Postal46614
Manufacturer Phone5742295409
Manufacturer G1HERAEUS KULZER GMBH
Manufacturer StreetALTE HEERSTRASSE B 802
Manufacturer CityDORMAGEN 41538
Manufacturer CountryGM
Manufacturer Postal Code41538
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NamePALAXPRESS ULTRA POWDER AND LIQUID
Generic NameEBI RESIN, DENTURE, RELINING, REPAIRING
Product CodeEBI
Date Received2012-11-19
Model NumberPINK
Catalog Number66034252
Lot Number012063
Device Expiration Date2015-05-01
OperatorLAY USER/PATIENT
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerHERAEUS KULZER GMBH
Manufacturer AddressDORMAGEN GM


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization 2012-11-19

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.